Ascendis Pharma Europe A/S — Credit Rating and Financial Key Figures

Ascendis Pharma Europe A/S (CVR number: 44420449) is a company from GENTOFTE. The company recorded a gross profit of 34.9 mEUR in 2025. The operating profit was 1008 kEUR, while net earnings were 892 kEUR. The profitability of the company measured by Return on Assets (ROA) was 6.8 %, which can be considered decent but Return on Equity (ROE) was 180.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 2.8 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. Ascendis Pharma Europe A/S's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.